1. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma
- Author
-
Keisuke Okamura, Toshiaki Shichinohe, Toru Yamada, Toru Nakamura, Aya Matsui, Hideyuki Hayashi, Tomoko Mitsuhashi, Kyoko Fujii, Shigeki Tanishima, Takahiro Tsuchikawa, Toshimichi Asano, Ryo Mori, Yusuke Watanabe, Satoshi Hirano, Takehiro Noji, Kimitaka Tanaka, Soichi Murakami, Yoshitsugu Nakanishi, Yo Kurashima, and Yuma Ebihara
- Subjects
Pathology ,medicine.medical_specialty ,Hepatology ,business.industry ,Gastroenterology ,Cholangiocarcinoma ,Extrahepatic Cholangiocarcinoma ,Bile Ducts, Intrahepatic ,medicine.anatomical_structure ,Bile Duct Neoplasms ,Lymphatic Metastasis ,Mutation ,medicine ,Amplicon sequencing ,Humans ,In patient ,Lymph Nodes ,business ,Lymph node - Abstract
Lymph node metastasis (LNM) is one of the most adverse prognostic factors in extrahepatic cholangiocarcinoma (EHCC) cases. As next-generation sequencing technology has become more widely available, the genomic profile of biliary tract carcinoma has been clarified. However, whether LNMs have additional genomic alterations in patients with EHCC has not been investigated. Here, we aimed to compare the genomic alterations between primary tumors and matched LNMs in patients with EHCC.Sixteen patients with node-positive EHCCs were included. Genomic DNA was extracted from tissue samples of primary tumors and matched LNMs. Targeted amplicon sequencing of 160 cancer-related genes was performed.Among the 32 tumor samples from 16 patients, 91 genomic mutations were identified. Genomic mutations were noted in 31 genes, including TP53, MAP3K1, SMAD4, APC, and ARID1A. TP53 mutations were most frequently observed (12/32; 37.5%). Genomic mutation profiles were highly concordant between primary tumors and matched LNMs (13/16; 81.3%), and an additional genomic mutation of CDK12 was observed in only one patient.Genomic mutations were highly concordant between primary tumors and matched LNMs, suggesting that genotyping of archived primary tumor samples may help predict genomic mutations of metastatic tumors in patients with EHCC.
- Published
- 2022